EZH2 has been shown to interact with PCNA-associated factor (PAF) to the β-catenin complex, and thereby promoting transcriptional activation of Wnt target genes, which is independent of methyltransferase activity of EZH2, in colon cancer cells [23]. This evidence concerns the gene PCLAF and malignant colon neoplasm.